Heart News and Research

RSS

Artificial intelligence helps patients better comprehend medical findings

Medical reports written in technical terminology can pose challenges for patients. A team at the Technical University of Munich (TUM) has investigated how artificial intelligence can make CT findings easier to understand.

21 Nov 2025

Reduced ketone body metabolism may be key to impaired energy production in type 2 diabetes

The liver plays a central role in storing and supplying energy to the body. In type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD, commonly referred to as fatty liver disease), mitochondria-the cell's power plants-cannot switch efficiently between fuel sources.

21 Nov 2025

Marine bacterium shows powerful therapeutic effects against colorectal cancer

A research team led by Professor Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology (JAIST), has discovered that the marine bacterium Photobacterium angustum demonstrates remarkable therapeutic efficacy against colorectal cancer.

21 Nov 2025

Breakthrough medium transforms canine stem cells into beating cardiomyocytes

In research, induced pluripotent stem (iPS) cells are derived from skin, urine, or blood samples and developed into other cells, like heart tissue, that researchers want to study.

21 Nov 2025

Digital and AI innovations in cardiology take center stage at ESC Digital & AI Summit

Smartphone stethoscopes, voice-detected heart failure, training using 3D-printed and virtual hearts and early detection of cardiovascular disease using blood spots are among the innovations being presented at the ESC Digital & AI Summit taking place in Berlin, Germany, 21–22 November.

21 Nov 2025

Blue light from tablets may not disrupt sleep in young children

The blue light that tablets emit is believed to make sleep less restful. However, an experimental study with young children was unable to confirm this assumption.

21 Nov 2025

UC Davis researchers lead $5.5 million study on language development in children with Down syndrome

UC Davis researchers are leading a $5.5 million study to better understand how children with Down syndrome develop expressive communication - the skills used to share what we want, think or feel.

21 Nov 2025

CAR T cell therapy could be a highly effective tool against atherosclerosis

A pioneering preclinical study has shown that CAR T cell therapy-a personalized form of immunotherapy used in cancer treatment-could be a highly effective tool against atherosclerosis, the condition where a build-up of plaque in the arteries reduces blood flow, leading to heart attacks and strokes.

21 Nov 2025

After series of denials, his insurer approved doctor-recommended cancer care. It was too late.

For nearly three years, Eric Tennant endured chemotherapy infusions, rounds of radiation, biopsies, and hospitalizations that left him weak and depleted.

21 Nov 2025

Even one cigarette a day harms the heart at every level

Smoking elevates heart disease and mortality risks. Cessation initiates a powerful recovery, reducing risks significantly within two decades.

21 Nov 2025

Eating lean beef as part of MED diet could improve gut diversity

Incorporating lean beef into a Mediterranean diet reduces TMAO levels and improves gut health, highlighting the importance of dietary patterns for wellness.

21 Nov 2025

Oral GLP-1 pill shows strong weight loss and blood sugar benefits in adults with diabetes

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher.

20 Nov 2025

Nationwide study maps epilepsy incidence rates among older adults in the United States

A first-of-its-kind nationwide study has mapped epilepsy incidence rates among older adults in the United States and identified key social and environmental factors associated with the neurological condition.

20 Nov 2025

UK Biobank releases the world’s largest metabolomic dataset for disease research

UK Biobank has today [Thursday 20 November] released the final set of data on nearly 250 metabolites – the molecules in our blood produced by our bodies as we go about our lives – in half a million volunteers.

20 Nov 2025

Study compares GLP-1 drug benefits and finds substantial variation in clinical effects

GLP-1 receptor agonists improve glycaemic control and provide renal, metabolic, and selective cardiovascular benefits in people with type 2 diabetes, based on an umbrella review of 17 meta-analyses. However, these agents consistently increase gastrointestinal adverse effects and show important distinctions between class-level outcomes and individual drug effects, particularly for semaglutide.

20 Nov 2025

Midlife exercise cuts dementia risk by up to 45 percent, new study shows

Higher physical activity in midlife and late life is linked to a substantially lower risk of all-cause and Alzheimer’s dementia. Midlife benefits are strongest for moderate or heavy activity, while late-life activity is protective across all intensity levels.

20 Nov 2025

Evidence links severe gum disease to erectile dysfunction and broader men’s health risks

A healthy mouth is also key to a healthy body, as gum disease has been linked to non-communicable diseases such as diabetes, cardiovascular disease, rheumatoid arthritis and Alzheimer's.

20 Nov 2025

Study develops highly accurate polygenic risk models tailored for Han Chinese populations

Researchers at Academia Sinica have developed the first population-specific polygenic risk score (PRS) models for people of Han Chinese ancestry, achieving unprecedented accuracy in predicting risks for common diseases such as diabetes, heart disease, autoimmune disorders.

20 Nov 2025

Study compares the kidney, cardiovascular and mortality risks of three different GLP-1 RAs

Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent years, with popular types like semaglutide (sold under brand names like Ozempic and Wegovy) becoming known for their weight-loss effects.

20 Nov 2025

New type of mitochondrial DNA damage revealed

A previously unknown type of DNA damage in the mitochondria, the tiny power plants inside our cells, could shed light on how our bodies sense and respond to stress.

20 Nov 2025

Previous
1
...
87
88
89
90
91
92
93
...
2531
Next

Heart News and Research

Artificial intelligence helps patients better comprehend medical findings

Reduced ketone body metabolism may be key to impaired energy production in type 2 diabetes

Marine bacterium shows powerful therapeutic effects against colorectal cancer

Breakthrough medium transforms canine stem cells into beating cardiomyocytes

Digital and AI innovations in cardiology take center stage at ESC Digital & AI Summit

Blue light from tablets may not disrupt sleep in young children

UC Davis researchers lead $5.5 million study on language development in children with Down syndrome

CAR T cell therapy could be a highly effective tool against atherosclerosis

After series of denials, his insurer approved doctor-recommended cancer care. It was too late.

Even one cigarette a day harms the heart at every level

Eating lean beef as part of MED diet could improve gut diversity

Oral GLP-1 pill shows strong weight loss and blood sugar benefits in adults with diabetes

Nationwide study maps epilepsy incidence rates among older adults in the United States

UK Biobank releases the world’s largest metabolomic dataset for disease research

Study compares GLP-1 drug benefits and finds substantial variation in clinical effects

Midlife exercise cuts dementia risk by up to 45 percent, new study shows

Evidence links severe gum disease to erectile dysfunction and broader men’s health risks

Study develops highly accurate polygenic risk models tailored for Han Chinese populations

Study compares the kidney, cardiovascular and mortality risks of three different GLP-1 RAs

New type of mitochondrial DNA damage revealed

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News